Linking transmission dynamics and economic evaluation to assess schistosomiasis programme strategies across districts in Malawi

This study utilizes an integrated transmission and economic model across Malawi's 32 districts to demonstrate that while school-aged child treatment is highly cost-effective for morbidity reduction, community-wide mass drug administration is necessary for elimination and becomes cost-saving only in high-prevalence districts, highlighting the need for strategies tailored to local disease burden and programmatic goals.

The Gist

Imagine Malawi as a large garden plagued by a stubborn, invisible weed called schistosomiasis. This weed doesn't just hurt the plants; it steals their energy, stunts their growth, and makes it hard for the whole garden to thrive. For years, gardeners (health officials) have been trying to control it by focusing their efforts on the young saplings (school-aged children), because that's where the wilting is most obvious.

This paper is like a detailed simulation run by a team of expert gardeners and accountants. They built a "digital twin" of Malawi's 32 districts to test different ways to pull out these weeds from 2024 all the way to 2050. They wanted to answer two big questions: How do we stop the weeds from hurting people today? and How do we get rid of the weeds forever?

Here is what they found, broken down into simple concepts:

1. The Hidden Reservoir: The "Adult Weeds"

The researchers discovered something surprising. While the young saplings (children) are the ones getting visibly sick, the biggest hidden reservoir of the weed is actually in the adults.

• The Metaphor: Think of the children as the visible flowers that are wilting, but the adults are the deep, tangled roots underground. Even if you water the flowers perfectly, if you ignore the roots, the weed keeps growing back.
• The Finding: In the absence of any new treatment, the vast majority of the "infection years" (time spent sick) would happen in adults, not children.

2. The Three Strategies Tested

The team tested three different ways to manage the garden:

• Strategy A: The "School Gate" Approach (Treating only children)
  • What it does: This is the current standard. It's like putting a fence around the school and treating only the kids inside.
  • The Result: It's very cheap and very effective at stopping the kids from getting sick. It's a "great deal" for the money spent. However, because it ignores the adult roots, the weed never fully disappears. The garden stays infested, just less visibly.
• Strategy B: The "Playground" Approach (Treating children and toddlers)
  • What it does: This expands the fence to include preschoolers.
  • The Result: It helps a tiny bit more, but it costs a lot more money for very little extra health gain. In most districts, this was a "bad deal"—you spent a fortune for a result you could have gotten cheaper with Strategy A.
• Strategy C: The "Whole Garden" Approach (Treating everyone)
  • What it does: This involves treating every single person, from toddlers to grandparents.
  • The Result: This is the only strategy that actually kills the weed completely (elimination) in every district by 2030. By pulling the adult roots, the weed stops coming back.
  • The Catch: It is very expensive upfront. However, because it stops the need for future treatments forever, in the worst-hit districts, it actually ends up saving money in the long run compared to just treating kids and never finishing the job.

3. The "One Size Does Not Fit All" Rule

The most important lesson from this paper is that you can't use the same plan for every district.

• The Metaphor: Imagine the garden has 32 different plots. Some plots are dry and have very few weeds (low burden). Others are swampy and thick with weeds (high burden).
• The Finding:
  • In the low-burden plots, treating just the kids is enough. Trying to treat everyone there is a waste of money.
  • In the high-burden plots (the swampy ones), treating just the kids is like trying to bail out a boat with a teaspoon. You must treat the adults to stop the water from coming back. In these specific areas, the "Whole Garden" approach is the only way to win.

4. The "Clean Water" Factor

The study also looked at improving sanitation (clean water and toilets), which is like fixing the soil so the weeds can't grow as easily.

• The Result: Better sanitation helps, but it's a slow process. It's like adding mulch to the soil; it helps over time, but it doesn't replace the need to pull the weeds. You still need the treatments (the "pulling") to get the job done quickly.

The Bottom Line

The paper concludes that there is a tension between two goals:

1. Short-term relief: If you just want to stop kids from being sick now and have a tight budget, treat the children. It's the most cost-effective way to reduce suffering immediately.
2. Long-term freedom: If you want to eliminate the disease entirely so no one has to be treated again, you must treat the adults too, especially in the worst-hit areas.

The authors suggest that Malawi (and similar places) shouldn't just pick one plan for the whole country. Instead, they should look at each district like a different plot in a garden: use the cheap, kid-focused plan where the weeds are light, and switch to the expensive, "treat-everyone" plan where the weeds are deep and dangerous. This way, they can save money while still aiming for a weed-free future.

Technical Summary

Technical Summary: Linking Transmission Dynamics and Economic Evaluation for Schistosomiasis Control in Malawi

Problem Statement
Schistosomiasis control in sub-Saharan Africa faces a strategic tension between sustaining morbidity reduction (primarily in school-aged children) and achieving transmission elimination. While preventive chemotherapy has reduced morbidity, persistent adult infection reservoirs and heterogeneous transmission dynamics across districts often prevent elimination. Current national programs frequently rely on uniform treatment schedules that may not reflect local epidemiological realities or the economic trade-offs required to shift from control to elimination. There is a need for frameworks that integrate biological transmission processes with health-system constraints and economic decision-making to determine optimal age-targeting and district-level prioritization.

Methodology
The authors developed a health-system-integrated transmission and economic evaluation framework using the Thanzi la Onse (TLO) individual-based model. The study simulated Schistosoma haematobium and S. mansoni transmission across all 32 districts of Malawi from 2024 to 2050.

• Model Structure: The TLO model simulates population dynamics, age-structured infection processes, care-seeking behavior, diagnostic pathways, and commodity availability. It incorporates species-specific transmission coefficients, age-dependent exposure, and stochastic worm acquisition.
• Intervention Scenarios: Five scenarios were evaluated against a baseline of no Mass Drug Administration (MDA):
  1. MDA targeting School-Aged Children (SAC; 5–14 years).
  2. MDA targeting Preschool- and School-Aged Children (PSAC+SAC; 2–14 years).
  3. Community-wide MDA (All ages ≥2 years).
  4. Water, Sanitation, and Hygiene (WASH) scale-up only.
  5. A "Pause WASH" scenario to test sensitivity.
• Economic Evaluation: Cost-effectiveness was assessed using Incremental Cost-Effectiveness Ratios (ICERs), Net Health Benefit (NHB), and Maximum Allowable Delivery Costs (MADC). The analysis utilized a cost-effectiveness threshold of 88 USD per Disability-Adjusted Life Year (DALY) averted, based on Malawi's opportunity cost. Costs included consumables (praziquantel) and implementation costs (management, delivery).
• Outcomes: Key metrics included person-years (PY) of infection, DALYs averted, and the probability of achieving elimination (defined as <2% prevalence in all ages).

Key Results

• Infection Burden: Without MDA, the majority of the infection burden (219.6 million PY) over the study period would reside in adults (≥15 years), compared to 72.8 million PY in SAC and 25.5 million PY in preschool-aged children.
• Epidemiological Impact:
  • MDA SAC: Reduced SAC infection by 88% and adult infection by 54.6% via indirect effects but failed to achieve elimination in most districts by 2050.
  • MDA PSAC+SAC: Produced modest additional gains (averting ~44,500 additional DALYs nationally) but was generally not cost-effective compared to SAC-only strategies, except in the high-burden Likoma district.
  • MDA All (Community-wide): The only strategy achieving elimination (<2% prevalence) for both species in all 32 districts by 2030. It averted a further 98,000 DALYs compared to PSAC+SAC.
• Cost-Effectiveness:
  • MDA SAC: Highly cost-effective nationally (ICER 4.76 USD/DALY) and in 25 of 32 districts (≥90% probability).
  • MDA PSAC+SAC: Generally dominated or not cost-effective (National ICER 606 USD/DALY).
  • MDA All: Showed heterogeneous results. It was cost-saving relative to PSAC+SAC in 11 high-prevalence districts (where elimination shortened program duration) but dominated in 16 other districts where pediatric strategies already reduced transmission significantly.
• Fiscal Feasibility: Maximum allowable delivery costs (MADC) were strongly correlated with baseline disease burden. High-burden districts supported substantially higher per-treatment implementation costs (up to ~38 USD) compared to low-burden districts (<3 USD).

Key Contributions

1. Integrated Framework: The study bridges transmission dynamics and economic evaluation at the district level, explicitly modeling health-system constraints (e.g., drug stock, staffing) and WASH transitions.
2. Elimination vs. Morbidity Trade-offs: It quantifies the specific conditions under which expanding treatment to adults is justified. The findings suggest that while pediatric strategies are optimal for short-term morbidity reduction, community-wide treatment is necessary for elimination, particularly in high-burden districts with large adult reservoirs.
3. Dynamic Stopping Rules: Unlike fixed-horizon analyses, this model incorporates elimination-based stopping rules, revealing that community-wide MDA can be cost-saving in high-burden settings by permanently removing the need for ongoing treatment.
4. District-Level Heterogeneity: The analysis demonstrates that a "one-size-fits-all" national strategy is suboptimal; economic value and elimination feasibility vary significantly across Malawi's districts.

Significance and Claims
The paper argues that the choice of schistosomiasis strategy must depend on whether the program prioritizes short-term morbidity reduction or long-term elimination, as well as local disease burden and service delivery costs.

The authors claim that integrating district-level transmission dynamics with opportunity-cost-based economic evaluation provides a framework for designing "fiscally grounded elimination pathways." They highlight a structural tension: strategies optimized for morbidity control (treating children) differ from those required for transmission interruption (treating all ages). The study suggests that while community-wide MDA is not universally cost-effective under standard DALY metrics, it becomes economically favorable in high-burden districts where the long-term payoff of elimination (avoided future costs and productivity losses) outweighs the immediate increase in spending. The findings support geographically targeted expansion rather than uniform national scaling, acknowledging that fiscal constraints may necessitate prioritizing high-risk districts for community-wide approaches while maintaining pediatric-focused strategies elsewhere.